Rapid Micro Biosystems (RPID) Gross Margin (2020 - 2026)

Rapid Micro Biosystems has disclosed Gross Margin across 7 years of filings, most recently posting 4.64% for Q1 2026.

• Gross Margin for Q1 2026 came in at 4.64%, down 97.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 50.67% (up 729.0% YoY), and the FY2025 annual result was 64.03%, up 1132.0% from the prior year.
• Gross Margin came in at 4.64% for Q1 2026 at Rapid Micro Biosystems, down from 70.55% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 70.55% in Q4 2025 to a low of 4.64% in Q1 2026.
• The 5-year median for Gross Margin is 41.53% (2024), against an average of 36.29%.
• Across the five-year window, Gross Margin sank 3933 bps in 2022 and surged 4440 bps in 2023, its largest moves.
• Rapid Micro Biosystems' Gross Margin stood at 5.72% in 2022, then surged by 777 bps to 50.12% in 2023, then rose by 27 bps to 63.71% in 2024, then advanced by 11 bps to 70.55% in 2025, then slumped by 93 bps to 4.64% in 2026.
• The last three Gross Margin figures came in at 4.64% (Q1 2026), 70.55% (Q4 2025), and 63.06% (Q3 2025), per Business Quant data.